Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: A matter of controversies [3] (multiple letters)

Blood

Volumn 97, Issue 11, 2001, Pages 3671-3675

  Creutzig, Ursula ^a   Reinhardt, Dirk ^a   Zimmermann, Martin ^a   Klingebiel, Thomas ^a   Gadner, Helmut ^a   Horan, John ^a   Korones, Dave ^a   Pinkel, Donald ^a   Woods, William G ^a   Lange, Beverly J ^a   Smith, Franklin O ^a   Alonzo, Todd A ^a  

^a Padiatrische Hamatologie/Onkologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DOWN SYNDROME; FANCONI ANEMIA; GRANULOCYTIC SARCOMA; HUMAN; LETTER; LEUKEMIA REMISSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME;

EID: 0035383818     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3671     Document Type: Letter

References (0)